BCM
NEO icon

Burrage Capital Management’s NeoGenomics NEO Stock Holding History

Burrage Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-147,921
Closed -$6.68M – 14
2021
Q2 		$6.68M Hold
147,921
– – 6.7% 5
2021
Q1 		$7.13M Sell
147,921
-30,856
-17% -$1.61M 5.78% 5
2020
Q4 		$9.63M Sell
178,777
-13,894
-7% -$628K 7.34% 3
2020
Q3 		$7.11M Buy
192,671
+2,466
+1% +$91.7K 5.61% 7
2020
Q2 		$5.89M Sell
190,205
-2,072
-1% -$57.4K 4.12% 10
2020
Q1 		$5.24M Sell
192,277
-6,071
-3% -$182K 5.16% 4
2019
Q4 		$5.8M Buy
+198,348
New +$4.72M 3.89% 11

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Burrage Capital Management's NEO Position: Q3 2021 in Review

Burrage Capital Management sold out of NeoGenomics (NEO) in Q3 2021, closing a stake of 147,921 shares — an estimated $6.68M sold.

Burrage Capital Management first reported a position in NEO in Q4 2019 and held it in 7 quarters. The position peaked at $9.63M in Q4 2020. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

  • Burrage Capital Management reported no remaining NeoGenomics position as of Q3 2021 after selling out during the quarter.
  • Burrage Capital Management sold 147,921 NeoGenomics shares in Q3 2021, an estimated $6.68M.
  • Burrage Capital Management first reported a position in NeoGenomics in Q4 2019 and held it in 7 quarters.
  • Burrage Capital Management's NeoGenomics position peaked at $9.63M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.